Real judgements, distilled

Legal Case Shots

Court judgements broken down into the case type, how the decision played out, and the lesson worth remembering, with the full judgement available as a PDF.

Service & Administrative LawSupreme Court of India

Union of India & Ors. v. M/s. Cipla Ltd. & Anr.

Civil Appeal · Neutral citation not assigned (Civil Appeal No. 329 of 2005)Decided 21 Oct 2016
Civil Appeal No. 329 of 2005
Justice Madan B. Lokur · Justice R.K. Agrawal

Background

Pharmaceutical companies, including Cipla, challenged a series of Central Government notifications issued between 1999 and 2003 under the Drugs (Prices Control) Order, 1995, which fixed norms for conversion cost, packing charges, and process loss, and which were used to set retail and ceiling prices for bulk drugs and formulations. The companies argued the notifications were issued mechanically, without proper application of mind, and without the annual re-determination the Order required, and had filed writ petitions in multiple High Courts (including Allahabad, Bombay and Karnataka) challenging various notifications and demand notices. The Union of India appealed High Court rulings that had gone against it, while Dr. Reddy's Laboratories separately appealed a ruling that had gone against the company.

Decision Breakdown

The Supreme Court answered each of the four legal questions framed in favour of the Government: it held the 1999 notification and its subsequent annual re-notifications were validly issued and not mechanical, that annual re-determination of norms was not legally required, that retail/ceiling price notifications were valid even without a separately determined packing-cost norm, and that fixing a formulation's retail price did not require first fixing the bulk drug's sale price. It also made two broader observations: criticising the Union of India for placing scanty material before the High Courts while dumping voluminous records only at the Supreme Court stage, and cautioning courts generally to be circumspect about granting interim relief that stays price-control notifications, since such orders can seriously harm public interest given the scale of the drug industry. On Cipla's alleged non-disclosure of a parallel Bombay High Court filing, the Court found no deliberate concealment and declined to non-suit Cipla on that ground alone. The appeals filed by the Union of India were allowed and the impugned judgments set aside; Dr. Reddy's Laboratories' appeals were dismissed, with no costs.

Lesson Learnt

Government price-control notifications under statutory price-control orders carry a presumption of validity unless shown to be issued without application of mind, and courts should be cautious about staying such notifications through interim orders because of their wide public-interest impact on affordable medicine pricing for ordinary consumers.

Union of India & Ors. v. M/s. Cipla Ltd. & Anr. – Legal Case Shots | LegalAware